Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Roberts

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
European Journal of Human Genetics : EJHG|March 26, 2015
Guidelines for cytogenetic investigations in tumoursRosalind J Hastings, Nick Bown, Maria G Tibiletti, et al.
Nature Genetics|August 14, 2019
Adaptation of host transmission cycle during Clostridium difficile speciationNitin Kumar, Hilary P Browne, Elisa Viciani, et al.
Journal of Medical Microbiology|August 5, 2015
Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains?Mitsutoshi Senoh, Haru Kato, Tadashi Fukuda, et al.
Circulation. Arrhythmia and Electrophysiology|November 13, 2025
One-Year Outcomes of the MODULAR ATP Trial: A Novel Leadless Pacemaker in Wireless Communication With a Subcutaneous Implantable Cardioverter DefibrillatorMichael S Lloyd, Vivek Y Reddy, Paul Roberts, et al.
Research Square|May 13, 2022
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim AnalysisEvan Anderson, Lisa Jackson, Nadine Rouphael, et al.
Nature Genetics|December 11, 2012
Emergence and global spread of epidemic healthcare-associated Clostridium difficileMiao He, Fabio Miyajima, Paul Roberts, et al.
Research Square|May 19, 2023
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) TrialAngela Branche, Nadine Rouphael, David Diemert, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
European Journal of Human Genetics : EJHG|March 26, 2015
Guidelines for cytogenetic investigations in tumoursRosalind J Hastings, Nick Bown, Maria G Tibiletti, et al.
Nature Genetics|August 14, 2019
Adaptation of host transmission cycle during Clostridium difficile speciationNitin Kumar, Hilary P Browne, Elisa Viciani, et al.
Journal of Medical Microbiology|August 5, 2015
Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains?Mitsutoshi Senoh, Haru Kato, Tadashi Fukuda, et al.
Circulation. Arrhythmia and Electrophysiology|November 13, 2025
One-Year Outcomes of the MODULAR ATP Trial: A Novel Leadless Pacemaker in Wireless Communication With a Subcutaneous Implantable Cardioverter DefibrillatorMichael S Lloyd, Vivek Y Reddy, Paul Roberts, et al.
Research Square|May 13, 2022
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim AnalysisEvan Anderson, Lisa Jackson, Nadine Rouphael, et al.
Nature Genetics|December 11, 2012
Emergence and global spread of epidemic healthcare-associated Clostridium difficileMiao He, Fabio Miyajima, Paul Roberts, et al.
Research Square|May 19, 2023
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) TrialAngela Branche, Nadine Rouphael, David Diemert, et al.
Pageof 12